Cholestasis in ulcerative colitis. Long term complications and medical therapy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D001647:Bile Acids and Salts; D002761:Cholangitis / Q000188:drug therapy / Q000209:etiology*; D002769:Cholelithiasis / Q000209:etiology; D002779:Cholestasis / Q000188:drug therapy / Q000209:etiology*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000150:complications*; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology; D008100:Liver Abscess / Q000209:etiology; D008103:Liver Cirrhosis / Q000209:etiology; D008286:Malabsorption Syndromes / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011537:Pruritus / Q000209:etiology; D012598:Sclerosis; D014815:Vitamins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001647:Bile Acids and Salts; D014815:Vitamins; D002792:Cholestyramine Resin; D001379:Azathioprine; D011241:Prednisone